FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Haruhiko Osawa

Research Profile

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Geographic Areas

Japan

Physiology

Concepts & Ideas

Anatomy

Adipocytes

Living Beings

Co-author Network

Publications

TOP 3
Hiroshi Onuma; Haruhiko Osawa; Mikiko Tohyama; Toshiaki Hanafusa; Koji Hashimoto; Akihisa Imagawa; Yoko Kano; Tetsuro Kobayashi; Hideichi Makino; Jun Ohashi
High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome.
Yasuharu Tabara; Hiroshi Onuma; Haruhiko Osawa; Ikki Shimizu; Ryuichi Kawamoto; Katsuhiko Kohara; Hideichi Makino; Tetsuro Miki
Genotype risk score of common susceptible variants for prediction of type 2 diabetes mellitus in Japanese: the Shimanami Health Promoting Program (J-SHIPP study). Development of type 2 diabetes mellitus and genotype risk score.
Yasuharu Tabara; Yasunori Takata; Ryoichi Kawamura; Katsuhiko Kohara; Tetsuro Miki; Wataru Nishida; Hiroshi Onuma; Haruhiko Osawa; Isao Saito; Susumu Sakurai; Takeshi Tanigawa
Relatively lower central aortic pressure in patients with impaired insulin sensitivity and resistance: the Toon Health Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Haruhiko Osawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hiroshi Onuma; Haruhiko Osawa; Mikiko Tohyama; Toshiaki Hanafusa; Koji Hashimoto; Akihisa Imagawa; Yoko Kano; Tetsuro Kobayashi; Hideichi Makino; Jun Ohashi
High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome.
The Journal of clinical endocrinology and metabolism 2012;97(12):E2277-81.
2011: Yasuharu Tabara; Hiroshi Onuma; Haruhiko Osawa; Ikki Shimizu; Ryuichi Kawamoto; Katsuhiko Kohara; Hideichi Makino; Tetsuro Miki
Genotype risk score of common susceptible variants for prediction of type 2 diabetes mellitus in Japanese: the Shimanami Health Promoting Program (J-SHIPP study). Development of type 2 diabetes mellitus and genotype risk score.
Metabolism: clinical and experimental 2011;60(11):1634-40.
2011: Yasuharu Tabara; Yasunori Takata; Ryoichi Kawamura; Katsuhiko Kohara; Tetsuro Miki; Wataru Nishida; Hiroshi Onuma; Haruhiko Osawa; Isao Saito; Susumu Sakurai; Takeshi Tanigawa
Relatively lower central aortic pressure in patients with impaired insulin sensitivity and resistance: the Toon Health Study.
Journal of hypertension 2011;29(10):1948-54.
2010: Hiroshi Onuma; Yasuharu Tabara; Ryuichi Kawamoto; Ikki Shimizu; Ryoichi Kawamura; Yasunori Takata; Wataru Nishida; Jun Ohashi; Tetsuro Miki; Katsuhiko Kohara; Hideichi Makino; Haruhiko Osawa
The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population.
Journal of human genetics 2010;55(9):600-4.
2010: Hiroshi Onuma; Yasuharu Tabara; Ryoichi Kawamura; Takashi Tanaka; Jun Ohashi; Wataru Nishida; Yasunori Takata; Masaaki Ochi; Kazuya Yamada; Ryuichi Kawamoto; Katsuhiko Kohara; Tetsuro Miki; Hideichi Makino; Haruhiko Osawa
A at single nucleotide polymorphism-358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population.
PloS one 2010;5(3):e9718.
2009: Yasuharu Tabara; Haruhiko Osawa; H Guo; Ryuichi Kawamoto; Hiroshi Onuma; Ikki Shimizu; Y Takara; Wataru Nishida; Miyuki Yamamoto; Hideichi Makino; Katsuhiko Kohara; Tsuneharu Miki
Prognostic significance of FTO genotype in the development of obesity in Japanese: the J-SHIPP study.
International journal of obesity (2005) 2009;33(11):1243-8.
2009: Haruhiko Osawa; Yasuharu Tabara; Ryuichi Kawamoto; Jun Ohashi; Masaaki Ochi; Hiroshi Onuma; Wataru Nishida; Kazuya Yamada; Jun Nakura; Tetsuro Miki; Hideichi Makino; Katsuhiko Kohara
PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population.
Clinical endocrinology 2009;71(3):341-5.
2009: Yasuharu Tabara; Haruhiko Osawa; Ryuichi Kawamoto; Hiroshi Onuma; Ikki Shimizu; Tetsuro Miki; Katsuhiko Kohara; Hideichi Makino
Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
Diabetes 2009;58(2):493-8.
2009: Haruhiko Osawa; Yasufumi Doi; Hideichi Makino; Toshiharu Ninomiya; Koji Yonemoto; Ryoichi Kawamura; Jun Hata; Yumihiro Tanizaki; Mitsuo Iida; Yutaka Kiyohara
Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study.
Cardiovascular diabetology 2009;8():60.
2008: Hiroshi Onuma; Haruhiko Osawa; Hideichi Makino
[Role of resistin in insulin resistance].
Rinsho byori. The Japanese journal of clinical pathology 2008;56(8):698-704.
2008: Haruhiko Osawa; Masaaki Ochi; Yasuharu Tabara; Kenichi Kato; Junko Yamauchi; Yasunori Takata; Wataru Nishida; Hiroshi Onuma; Ikki Shimizu; Yasuhisa Fujii; Tetsuro Miki; Jun Ohashi; Hideichi Makino
Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
Clinical endocrinology 2008;69(1):74-80.
2008: Haruhiko Osawa; Kazuya Yamada; Yasuharu Tabara; Masaaki Ochi; Hiroshi Onuma; Wataru Nishida; Ikki Shimizu; Ryuichi Kawamoto; Yasuhisa Fujii; Tetsuro Miki; Jun Ohashi; Hideichi Makino
The G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.
Clinical endocrinology 2008;69(1):36-44.
2008: Satoshi Murao; Shiori Kondo; Jun Ohashi; Yasuhisa Fujii; Ikki Shimizu; Masao Fujiyama; Keizo Ohno; Yasuharu Takada; Kazuaki Nakai; Yukio Yamane; Haruhiko Osawa; Hideichi Makino
Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study.
Diabetes research and clinical practice 2008;80(1):114-21.
2008: Yasuharu Tabara; Haruhiko Osawa; Ryuichi Kawamoto; Rieko Tachibana-Iimori; Miyuki Yamamoto; Jun Nakura; Tetsuro Miki; Hideich Makino; Katsuhiko Kohara
Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study.
The Journal of clinical endocrinology and metabolism 2008;93(3):715-22.
2008: Junko Yamauchi; Haruhiko Osawa; Tomomi Takasuka; Masaaki Ochi; Akiko Murakami; Wataru Nishida; Hiroshi Onuma; Yasunori Takata; Yasuharu Tabara; Tetsuro Miki; Jun Ohashi; Hideichi Makino
Serum resistin is reduced by glucose and meal loading in healthy human subjects.
Metabolism: clinical and experimental 2008;57(2):149-56.
2008: Yasunori Takata; Haruhiko Osawa; Mie Kurata; Maki Kurokawa; Junko Yamauchi; Masaaki Ochi; Wataru Nishida; Takafumi Okura; Jitsuo Higaki; Hideichi Makino
Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes.
Hypertension 2008;51(2):534-9.
2008: Mai Nakamura; Wataru Nishida; Yuya Yamada; Daisuke Chujo; Yuji Watanabe; Akihisa Imagawa; Toshiaki Hanafusa; Eiji Kawasaki; Hiroshi Onuma; Haruhiko Osawa; Hideichi Makino
Insulin administration may trigger pancreatic beta-cell destruction in patients with type 2 diabetes.
Diabetes research and clinical practice 2008;79(2):220-9.
2008: Yasuharu Tabara; Ryuichi Kawamoto; Haruhiko Osawa; Jun Nakura; Hideichi Makino; Tetsuro Miki; Katsuhiko Kohara
No association between INSIG2 Gene rs7566605 polymorphism and being overweight in Japanese population.
Obesity (Silver Spring, Md.) 2008;16(1):211-5.
2007: Masaaki Ochi; Haruhiko Osawa; Yushi Hirota; Kazuo Hara; Yasuharu Tabara; Yoshiharu Tokuyama; Ikki Shimizu; Azuma Kanatsuka; Yasuhisa Fujii; Jun Ohashi; Tetsuro Miki; Naoto Nakamura; Takashi Kadowaki; Mitsuo Itakura; Masato Kasuga; Hideichi Makino
Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes.
Diabetes 2007;56(11):2834-8.
2007: Koji Shishino; Masaaki Ochi; Mitsuharu Murase; Haruhiko Osawa; Hideichi Makino
[Clinical significance of small, dense LDL cholesterol in patients with hyperlipidemia and type 2 diabetes].
Rinsho byori. The Japanese journal of clinical pathology 2007;55(8):705-11.
2007: Haruhiko Osawa; Yasuharu Tabara; Ryuichi Kawamoto; Jun Ohashi; Masaaki Ochi; Hiroshi Onuma; Wataru Nishida; Kazuya Yamada; Jun Nakura; Katsuhiko Kohara; Tetsuro Miki; Hideichi Makino
Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.
Diabetes care 2007;30(6):1501-6.
2007: Yoshiharu Tokuyama; Haruhiko Osawa; Toshiharu Ishizuka; Hiroshi Onuma; Kana Matsui; Toru Egashira; Hideichi Makino; Azuma Kanatsuka
Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2007;56(5):693-8.
2007: Haruhiko Osawa; Masaaki Ochi; Kenichi Kato; Junko Yamauchi; Wataru Nishida; Yasunori Takata; Ryoichi Kawamura; Hiroshi Onuma; Tomomi Takasuka; Ikki Shimizu; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
Serum resistin is associated with the severity of microangiopathies in type 2 diabetes.
Biochemical and biophysical research communications 2007;355(2):342-6.
2007: Koji Shishino; Masaaki Ochi; Mitsuharu Murase; Haruhiko Osawa; Hideichi Makino
[A simple separative method for measuring serum amyloid A in high-density-lipoprotein and low-density-lipoprotein fractions using the phosphotungstic acid-Mg2+ precipitation procedure].
Rinsho byori. The Japanese journal of clinical pathology 2007;55(4):319-24.
2006: Koji Shishino; Masaaki Ochi; Mitsuharu Murase; Haruhiko Osawa; Hideichi Makino
[Clinical significance of serum-glycated apolipoprotein B measured by the digestion LDL sediment fraction with protease].
Rinsho byori. The Japanese journal of clinical pathology 2006;54(6):583-8.
2005: Haruhiko Osawa; Hiroshi Onuma; Hideichi Makino
[Genetic testing and gene-based testing for type 2 diabetes].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 12():295-300.
2005: Hiroshi Onuma; Haruhiko Osawa; Takahiro Ogura; Fumiko Tanabe; Wataru Nishida; Hideichi Makino
A newly identified 50 kDa protein, which is associated with phosphodiesterase 3B, is phosphorylated by insulin in rat adipocytes.
Biochemical and biophysical research communications 2005;337(3):976-82.
2005: Haruhiko Osawa; Hiroshi Onuma; Masaaki Ochi; Akiko Murakami; Junko Yamauchi; Tomomi Takasuka; Fumiko Tanabe; Ikki Shimizu; Kenichi Kato; Wataru Nishida; Kazuya Yamada; Yasuharu Tabara; Masaki Yasukawa; Yasuhisa Fujii; Jun Ohashi; Tetsuro Miki; Hideichi Makino
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
Biochemical and biophysical research communications 2005;335(2):596-602.
2005: Mitsuru Hashiramoto; Haruhiko Osawa; Mitsuhiro Ando; Akiko Murakami; Tatsuya Nishimiya; Masao Nakano; Wataru Nishida; Hiroshi Onuma; Hideichi Makino
A nonsense mutation in the Arg345 of the insulin receptor gene in a Japanese type A insulin-resistant patient.
Endocrine journal 2005;52(4):499-504.
2005: Koji Shishino; Yuki Yoshioka; Kaori Hashimoto; Masaaki Ochi; Kenji Aono; Mitsuharu Murase; Haruhiko Osawa; Hideichi Makino; Shuichi Saheki
A simple precipitation method for measuring sialic acid in apolipoprotein B-containing lipoproteins in plasma.
Annals of clinical biochemistry 2005;42(Pt 4):298-300.
2005: Koji Shishino; Masaaki Ochi; Mitsuharu Murase; Haruhiko Osawa; Hideichi Makino
[Convenient assay for glycated apolipoprotein B using protease].
Rinsho byori. The Japanese journal of clinical pathology 2005;53(6):504-8.
2005: Haruhiko Osawa; Hiroshi Onuma; Hideichi Makino
[Combined use of fasting plasma glucose and HbA1c (as a screening test)].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 2():390-3.
2004: Satoshi Murao; Hideichi Makino; Yukikazu Kaino; Etsushi Konoue; Jun Ohashi; Kaichi Kida; Yasuhisa Fujii; Ikki Shimizu; Eiji Kawasaki; Masao Fujiyama; Shiori Kondo; Kiyonobu Tanaka; Yoshinao Tarumi; Isamu Seto; Kenichi Kato; Keizo Ohno; Yukiko Kusunoki; Osamu Ebisui; Yasuharu Takada; Katsuya Tanabe; Koji Takemoto; Hiroshi Onuma; Tatsuya Nishimiya; Haruhiko Osawa
Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients.
Diabetes 2004;53(10):2684-90.
2004: Haruhiko Osawa; Kazuya Yamada; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Hiroko Kawata; Tatsuya Nishimiya; Toshiyuki Niiya; Ikki Shimizu; Wataru Nishida; Mitsuru Hashiramoto; Azuma Kanatsuka; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
American journal of human genetics 2004;75(4):678-86.
2003: Masaaki Ochi; Haruhiko Osawa; Hiroshi Onuma; Akiko Murakami; Tatsuya Nishimiya; Fumio Shimada; Kenichi Kato; Ikki Shimizu; Koji Shishino; Mitsuharu Murase; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes.
Diabetes research and clinical practice 2003;61(3):191-8.
2003: Takahiro Ogura; Haruhiko Osawa; Yan Tang; Hiroshi Onuma; Masaaki Ochi; Tatsuya Nishimiya; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Hideichi Makino
Reduction of phosphodiesterase 3B gene expression in peroxisome proliferator-activated receptor gamma (+/-) mice independent of adipocyte size.
FEBS letters 2003;542(1-3):65-8.
2003: Haruhiko Osawa; Toshiyuki Niiya; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Tatsuya Nishimiya; Takahiro Ogura; Kenichi Kato; Ikki Shimizu; Yasuhisa Fujii; Jun Ohashi; Kazuya Yamada; Shu-Jian Liang; Vincent C Manganiello; Yoko Fujita-Yamaguchi; Hideichi Makino
Systematic search for single nucleotide polymorphisms in the 5' flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes.
Molecular genetics and metabolism 2003;79(1):43-51.
2003: Haruhiko Osawa; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Tatsuya Nishimiya; Kenichi Kato; Ikki Shimizu; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
Systematic search for single nucleotide polymorphisms in the FOXC2 gene: the absence of evidence for the association of three frequent single nucleotide polymorphisms and four common haplotypes with Japanese type 2 diabetes.
Diabetes 2003;52(2):562-7.
2002: Hiroshi Onuma; Haruhiko Osawa; Kazuya Yamada; Takahiro Ogura; Fumiko Tanabe; Daryl K Granner; Hideichi Makino
Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein.
Diabetes 2002;51(12):3362-7.
2002: Masaaki Hasegawa; Yan Tang; Haruhiko Osawa; Hiroshi Onuma; Tatsuya Nishimiya; Masaaki Ochi; Yasuo Terauchi; Takashi Kadowaki; Hideichi Makino
Differential regulation of gene expression and insulin-induced activation of phosphodiesterase 3B in adipocytes of lean insulin-resistant IRS-1 (-/-) mice.
Diabetes research and clinical practice 2002;58(2):79-85.
2002: Haruhiko Osawa; Hiroshi Onuma; Hideichi Makino
[Current status of study for type 2 diabetes susceptibility genes].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 8():271-6.
2002: Haruyo Takeda; Eiji Kawasaki; Ikki Shimizu; Etsushi Konoue; Masao Fujiyama; Satoshi Murao; Kiyonobu Tanaka; Kennichi Mori; Yoshinao Tarumi; Isamu Seto; Yasuhisa Fujii; Kenichi Kato; Shiori Kondo; Yasuharu Takada; Nobuaki Kitsuki; Yukikazu Kaino; Kaichi Kida; Naotake Hashimoto; Yukio Yamane; Takashi Yamawaki; Hiroshi Onuma; Tatsuya Nishimiya; Haruhiko Osawa; Yasushi Saito; Hideichi Makino
Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Diabetes care 2002;25(6):995-1001.
2002: Haruhiko Osawa; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Tatsuya Nishimiya; Kenichi Kato; Ikki Shimizu; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes.
Diabetes 2002;51(3):863-6.
2001: Haruhiko Osawa; M Ochi; Tatsuya Nishimiya; Hiroshi Onuma; K Nakamaru; A Murakami; K Kato; I Shimizu; Y Fujii; J Ohashi; H Makino
A systematic search for single nucleotide polymorphisms (SNPs) in the insulin receptor gene: association of an SNP with hyperlipidemia in Japanese type 2 diabetic subjects.
Clinical genetics 2001;60(6):479-81.
2001: Yan Tang; Haruhiko Osawa; Hiroshi Onuma; Tatsuya Nishimiya; Masaaki Ochi; A Sugita; Hideichi Makino
Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse.
Diabetes research and clinical practice 2001;54(3):145-55.
2001: Toshiyuki Niiya; Haruhiko Osawa; Hiroshi Onuma; Y Suzuki; M Taira; Kazuya Yamada; Hideichi Makino
Activation of mouse phosphodiesterase 3B gene promoter by adipocyte differentiation in 3T3-L1 cells.
FEBS letters 2001;505(1):136-40.
2001: Haruhiko Osawa; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Tatsuya Nishimiya; Kenichi Kato; Ikki Shimizu; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
Systematic search for single nucleotide polymorphisms in the insulin gene: evidence for a high frequency of -23T-->A in Japanese subjects.
Biochemical and biophysical research communications 2001;286(3):451-5.
2001: Yan Tang; Haruhiko Osawa; Hiroshi Onuma; M Hasegawa; Tatsuya Nishimiya; Masaaki Ochi; Hideichi Makino
Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(1):93-9.
2001: Haruhiko Osawa; Tatsuya Nishimiya; Masaaki Ochi; Toshiyuki Niiya; Hiroshi Onuma; F Kitamuro; Yukikazu Kaino; Kaichi Kida; Hideichi Makino
Identification of novel C253Y missense and Y864X nonsense mutations in the insulin receptor gene in type A insulin-resistant patients.
Clinical genetics 2001;59(3):194-7.
2001: Koji Shishino; Mitsuharu Murase; Yasuo Hitsumoto; Haruhiko Osawa; Hideichi Makino; Shuichi Saheki
[Clinical significance of serum LpA-I levels measured by immunoturbidimetric assay in type 2 diabetes mellitus patients].
Rinsho byori. The Japanese journal of clinical pathology 2001;49(1):39-44.
1999: Haruhiko Osawa; Hiroshi Onuma; M Hasegawa; Hideichi Makino
[Gene mutation associated with diabetes mellitus].
Nihon rinsho. Japanese journal of clinical medicine 1999;57 Suppl():739-45.
1999: Toshiyuki Niiya; Haruhiko Osawa; Shiro Bando; Y Oto; K Tokuda; N Takeda; M Sumioka; M Murase; Kaichi Kida; Hideichi Makino
A complete deficiency of coagulation factor XIII A-subunit due to a novel compound heterozygote of Ser 413 Leu missense and an nt 389 (ins G) frameshift mutation.
British journal of haematology 1999;107(4):772-5.
1999: Yan Tang; Haruhiko Osawa; Hiroshi Onuma; Tatsuya Nishimiya; Masaaki Ochi; Hideichi Makino
Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
Diabetes 1999;48(9):1830-5.
1999: Koji Shishino; Yasuo Hitsumoto; Haruhiko Osawa; Hideichi Makino; Shuichi Saheki
[Development of a serum lipoprotein A-I immunoassay method].
Rinsho byori. The Japanese journal of clinical pathology 1999;47(6):576-9.
1998: Hiroshi Onuma; Hideichi Makino; Haruhiko Osawa; Y Suzuki; M Taira; Azuma Kanatsuka; Y Saito
Mitogen-activated protein kinase and p70 ribosomal protein S6 kinase are not involved in the insulin-dependent stimulation of cAMP phosphodiesterase kinase in rat adipocytes.
Biochimica et biophysica acta 1998;1402(2):197-208.